These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25965538)

  • 21. Pulmonary toxicity after bevacizumab and concurrent thoracic radiotherapy observed in a phase I study for inoperable stage III non-small-cell lung cancer.
    Lind JS; Senan S; Smit EF
    J Clin Oncol; 2012 Mar; 30(8):e104-8. PubMed ID: 22331948
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictors of survival in postinduction therapy surgical T4N0-2 non-small cell lung cancer.
    Lococo F; Cesario A; Nachira D; Margaritora S; Granone P
    Ann Thorac Surg; 2013 Dec; 96(6):2284. PubMed ID: 24296212
    [No Abstract]   [Full Text] [Related]  

  • 23. [Not Available].
    Klee H
    Pneumologie; 2016 Dec; 70(12):835. PubMed ID: 27931060
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of stage III non-small cell lung cancer.
    Tabchi S; Kassouf E; Rassy EE; Kourie HR; Martin J; Campeau MP; Tehfe M; Blais N
    Semin Oncol; 2017 Jun; 44(3):163-177. PubMed ID: 29248128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of early-stage non-small-cell lung cancer (NSCLC).
    Le Chevalier T
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S292-3. PubMed ID: 21943988
    [No Abstract]   [Full Text] [Related]  

  • 26. Prologue.
    Duque Medina JL
    Arch Bronconeumol; 2016 May; 52 Suppl 1():1. PubMed ID: 27389766
    [No Abstract]   [Full Text] [Related]  

  • 27. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
    Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung disease left out in the cold.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2016 Jul; 4(7):527. PubMed ID: 27396761
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of the staging method on the prognostic utility of the 8th AJCC staging system for non-small-cell lung cancer.
    Abdel-Rahman O
    Future Oncol; 2017 Oct; 13(25):2277-2284. PubMed ID: 28976218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of lung cancer with chronic obstructive pulmonary disorder - What are the issues?
    Nakanishi Y
    Respir Investig; 2016 Nov; 54(6):385-386. PubMed ID: 27886848
    [No Abstract]   [Full Text] [Related]  

  • 31. Thoracic inspirations: advances in the diagnosis, staging, and treatment of non-small-cell lung cancer.
    Toloza EM
    Cancer Control; 2014 Jan; 21(1):4-5. PubMed ID: 24357735
    [No Abstract]   [Full Text] [Related]  

  • 32. The growth of palliative care.
    Strand JJ; Mansel JK; Swetz KM;
    Minn Med; 2014 Jun; 97(6):39-43. PubMed ID: 25029799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invited commentary.
    Van Schil PE
    Ann Thorac Surg; 2012 Dec; 94(6):1822. PubMed ID: 23176903
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary rehabilitation in non-small cell lung cancer patients after completion of treatment.
    Glattki GP; Manika K; Sichletidis L; Alexe G; Brenke R; Spyratos D
    Am J Clin Oncol; 2012 Apr; 35(2):120-5. PubMed ID: 21378541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controversies in Staging and Treatment of Locally Advanced Non-Small Cell Lung Cancers. 3rd IASLC Workshop on Therapy of Non-Small Lung Cancer. Bruges, 29 August-2 September 1993.
    Lung Cancer; 1994 Nov; 11 Suppl 3():S1-149. PubMed ID: 7704499
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population.
    Zhang J; Zhou JB; Lin XF; Wang Q; Bai CX; Hong QY
    Respirology; 2013 Feb; 18(2):297-302. PubMed ID: 23051099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The changed role of chemotherapy in the treatment of stage III non-small-cell lung carcinoma].
    Koning CC
    Ned Tijdschr Geneeskd; 1997 Jul; 141(30):1497-8. PubMed ID: 9542886
    [No Abstract]   [Full Text] [Related]  

  • 38. Multidisciplinary management of lung cancer.
    Spira A; Ettinger DS
    N Engl J Med; 2004 Jan; 350(4):379-92. PubMed ID: 14736930
    [No Abstract]   [Full Text] [Related]  

  • 39. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
    Sawa K; Koh Y; Kawaguchi T; Kambayashi S; Asai K; Mitsuoka S; Kimura T; Yoshimura N; Yoshimoto N; Kubo A; Saka H; Matsumura A; Wanibuchi H; Yamamoto N; Nishiyama N; Hirata K
    Lung Cancer; 2017 Oct; 112():96-101. PubMed ID: 29191607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-small cell lung cancer].
    Yoshimura A; Niitani H
    Ryoikibetsu Shokogun Shirizu; 1994; (4):100-3. PubMed ID: 8007089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.